✦ LIBER ✦

Efficacy and tolerability of tolterodine extended-release in continent patients with overactive bladder and nocturia

✍ Scribed by VICTOR W. NITTI; ROGER DMOCHOWSKI; RODNEY A. APPELL; JOSEPH T. WANG; TAMARA BAVENDAM; ZHONGHONG GUAN; the 037 Study Group

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and tolerability of tolterodine

✍ CLAUS G. ROEHRBORN; PAUL ABRAMS; ERIC S. ROVNER; STEVEN A. KAPLAN; SENDER HERSCH 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 142 KB

Long-term safety, tolerability and effic

✍ MINEO TAKEI; YUKIO HOMMA; THE JAPANESE TOLTERODINE STUDY GROUP 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 140 KB

The clinical efficacy of tolterodine ext

✍ Roger Dmochowski; Karl Kreder; Scott MacDiarmid; Martin Carlsson; Zhonghong Guan 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB

Effectiveness and tolerability of extend

✍ Rodney U. Anderson; Scott MacDiarmid; Sherron Kell; James H. Barada; Scott Serel 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 137 KB

Efficacy and tolerability of fesoterodin

✍ Peter K. Sand; Jon D. Morrow; Tamara Bavendam; Dana L. Creanga; Victor W. Nitti 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 220 KB

Comparison of fesoterodine and tolterodi

✍ Christopher R. Chapple; Philip E. Van Kerrebroeck; Klaus-Peter Jünemann; Joseph 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 182 KB